Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CR1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
AHNAK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C22orf23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAPGEF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLR3H - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VCL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENTHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SDK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
HOXC13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEPHS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLCS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSLP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PKDCC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TP53BP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on